Summary
The interaction of several non-benzodia-zepine drugs with [3H] diazepam binding to benzodiazepine receptors in rat brain synaptosomal membranes was investigated. Baclofen, benzoctamine, hydroxyzine, chlorpromazin, haloperidol, imipramine, and amitriptyline displace specific [3H] diazepam binding, but the concentrations needed are too high to explain pharmacological effects of these drugs by an interaction with benzodiazepine receptors. The most potent non-benzodiazepine drug for inhibiting specific [3H] diazepam binding was methaqualone (IC50 value of 150 μM). It is suggested that interactions with benzodiazepine receptors may account for the anxiolytic and anticonvulsive side effects of this drug. The analeptic drug pentylenetetrazole interacts with benzodiazepine receptor binding with an IC50 value of about 1 mM, which is possibly too high to explain its convulsive properties by an antagonism at the benzodiazepine receptor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bosmann, H. B., Penney, D. P., Case, K. R., DiStefano, P., Averill, K.: Diazepam receptor: Specific binding of [3H] diazepam and [3H]-flunitrazepam to rat brain subfractions. FEBS Letters 87, 199–202 (1978)
Braestrup, C., Albrechtsen, R., Squires, R. F.: High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702–704 (1977)
Braestrup, C., Squires, R. F.: Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H] diazepam binding. Proc. Natl. Acad. Sci. 74, 3805–3809 (1977)
Braestrup, C., Squires, R. F.: Pharmacological characterization of benzodiazepine receptors in the brain. Eur. J. Pharmacol. 48, 263–270 (1978)
Brown, S. S., Goenechea, S.: Methaqualone: Metabolic, kinetic, and clinical pharmacologic observations. Clin. Pharmacol. Ther. 14, 314–324 (1973)
Burt, D. R., Enna, S. J., Creese, I., Snyder, S. H.: Dopamine receptor binding in the corpus striatum of mammalian brain. Proc. Natl. Acad. Sci. 72, 4655–4659 (1975)
Chang, R. S. L., Snyder, S. H.: Benzodiazepine receptors: Labeling in intact animals with [3H] flunitrazepam. Eur. J. Pharmacol. 48, 213–218 (1978)
Creese, I., Burt, D. R., Snyder, S. H.: Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sci. 17, 993–1002 (1975)
Enna, S. J., Snyder, S. H.: Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. Brain Res. 100, 81–97 (1975)
Enna, S. J., Snyder, S. H.: GABA receptor binding in frog spinal cord and brain. J. Neurochem. 28, 857–860 (1977)
Haefely, W. E.: Synaptic pharmacology of barbiturates and benzodiazepines. Agents and Actions 7, 353–359 (1977)
Horn, A. S., Coyle, J. T., Snyder, S. H.: Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol. Pharmacol. 7, 66–80 (1971)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
MacDonald, R. L., Barker, J. L.: Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 267, 720–721 (1977)
Möhler, H., Okada, T.: Benzodiazepine receptor: Demonstration in the central nervous system. Science 198, 849–851 (1977a)
Möhler, H., Okada, T.: GABA receptor binding with 3H (+)bicucullinemethiodide in rat CNS. Nature 267, 65–67 (1977b)
Möhler, H., Okada, T., Heitz, Ph., Ulrich, J.: Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci. 22, 985–996 (1978)
Naik, S. R., Naik, P. R., Sheth, U. K.: Involvement of gamma-amino butyric acid (GABA) in the anticonvulsant action of methaqualone. Psychopharmacol. 57, 103–107 (1978)
Nicoll, R. A., Padjen, A.: Pentylenetetrazol: An antagonist of GABA at primary afferents of the isolated frog spinal cord. Neuropharmacol. 15, 69–71 (1976)
Ross, S. B., Renyi, A. L.: Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 7, 270–277 (1969)
Rowles, S. G., Born, G. S., Russell, H. T., Kessler, W. V., Christian, J. E.: Biological dispostion of pentylenetetrazol-10-14C in rats and humans. J. Pharm. Sci. 60, 725–727 (1971)
Speth, R. C., Wastek, G. J., Johnson, P. C., Yamamura, H. I.: Benzodiazepine binding in human brain: characterization using [3H] flunitrazepam. Life Sci. 22, 859–866 (1978)
Squires, R. F., Braestrup, C.: Benzodiazepine receptors in rat brain. Nature 266, 732–734 (1977)
Stumpf, Ch.: Pharmakologische Methoden. In: Handb. d. exp. Pharmakol. Erg.-W. Vol. XVI/7, (O. Eichler, ed.), Berlin: Springer-Verlag 1962
Zukin, S. R., Young, A. B., Snyder, S. H.: Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc. Natl. Acad. Sci. 71, 4802–4807 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, W.E., Schläfer, U. & Wollert, U. Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 305, 23–26 (1978). https://doi.org/10.1007/BF00497002
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00497002